The gene-edited babies controversy got all the headlines, but there’s a lot more going on with the technology known as CRISPR these days.

Join STAT senior science writer Sharon Begley and senior biotech writer Adam Feuerstein for this CRISPR webinar. They’ll get you up to speed on the latest science, introduce you to some preclinical work that hints at diseases CRISPR might one day treat, and update you on ongoing human trials.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy